- Business Wire•16 days agoPURE Bioscience Sets Q2 Results Conference Call to Review Sales and Progress of its SDC-Based Antimicrobial Food Safety Solutions Strategy
PURE Bioscience, Inc. , creator of the patented non-toxic silver dihydrogen citrate antimicrobial, announced today that the Company will publish fiscal Q2 results after the market closes and host an investor conference call on Thursday, March 2, 2017 at 1:30 p.m.
- Business Wire•19 days agoPURE Bioscience Receives FDA Interim Safety Determination Authorization to Test Higher Concentrations of SDC-Based PURE Control® Antimicrobial as a Poultry Processing Aid
PURE Bioscience, Inc. , creator of the non-toxic, patented silver dihydrogen citrate antimicrobial, today announced the Company had received a Preliminary Notification authorization letter from the U.S.
- Business Wire•29 days agoRecent Norovirus Outbreaks in National Media Headlines - Highly Effective PURE® Hard Surface Disinfectant Kills Norovirus in 60 Seconds
PURE Bioscience, Inc. , creator of the patented silver dihydrogen citrate antimicrobial, has published a Norovirus Technical Bulletin highlighting the unique and powerful effectiveness of EPA-registered PURE® Hard Surface disinfectant and food contact surface sanitizer and its use to prevent and kill the Norovirus in 60 seconds.
PURE : Summary for PURE BIOSCIENCE IN COM NPV - Yahoo Finance
PURE Bioscience, Inc. (PURE)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.87 - 0.90|
|52 Week Range||0.75 - 1.28|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-4.22|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|